Small Caps TodaySmall Caps TodayBiotech
31 Articles
Dec 01, 2025
Zymeworks Stock Skyrockets After Cancer Breakthrough — But What’s Next?
8 min read8' read
Nov 24, 2025
Pacira BioSciences Pops As Activist Investor Calls For Sale — What You Need To Know!
8 min read8' read
Oct 24, 2025
Nektar Therapeutics Gains New Life On Buyout Rumors & Atopic Dermatitis Breakthrough
8 min read8' read
Jul 17, 2025
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
8 min read8' read
Jun 18, 2025
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions
8 min read8' read
Jun 10, 2025
Bristol Myers’ $11.1 Billion Bet on BioNTech: Is Oncology The New Growth Engine?
8 min read8' read
Jun 05, 2025
Eli Lilly’s $1 Billion Bet On SiteOne: Can Non-Opioid Pain Drugs Reshape The Pharma Giant’s Future?
8 min read8' read
Mar 10, 2025
Aspire Biopharma CEO Interview: Disrupting Drug Delivery with Sublingual Tech
8 min read8' read
Feb 20, 2025
Is Cytokinetics The Next Big Takeover Target? Here’s What You Need to Know!
7 min read7' read
Feb 20, 2025
Arcutis Biotherapeutics Surges Amid Takeover Speculation: Why Large Pharma Should Pay Attention!
6 min read6' read
Jan 15, 2025
Legend Biotech: Why The Recent Takeover Speculation Is Worth Your Attention!
5 min read5' read
Dec 04, 2024
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
5 min read5' read
SmallCaps Daily Sits Down with Milton Werner, President and CEO of Inhibikase Therapeutics
15 min read15' read
Discover top 10 categories
Let's explore the most popular categories
Join our newsletter 🎉
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account.
- 02Write your stories.
